Market Place
Sourcing Support
Trilantic: Invests In Strategic Growth Of SOFIE Biosciences
04 Jun 2024 //
BUSINESSWIRE
Life Molecular Imaging and SOFIE announce Neuraceq® availability in Cleveland
05 Apr 2024 //
PR NEWSWIRE
Jubilant Pharmova sells stake in Sofie Biosciences for $139.4 million
30 Jan 2024 //
ECONOMIC TIMES
Enforcement Report - Week of October 4, 2023
04 Oct 2023 //
FDA
First Patient Imaged in SOFIE`s 18F-FAPI Phase 2 trial
12 May 2023 //
PR NEWSWIRE
SOFIE granted IND for 18F-FAPI in Phase 2 study
29 Nov 2022 //
PRNEWSWIRE
SOFIE gets greenlight from FDA to proceed to Phase II Pancreatic Cancer Study
10 Nov 2021 //
PRNEWSWIRE
SOFIE Submits IND to US FDA for Pancreatic Cancer Imaging
12 Oct 2021 //
PRNEWSWIRE
Jubilant Radiopharma & SOFIE Ink Strategic Partnership Deal
04 Nov 2020 //
PRNEWSWIRE
Jubilant Radiopharma, SOFIE Biosciences Ink Strategic Pact
04 Nov 2020 //
CONTRACTPHARMA
Sofie Biosciences To Acquire Zevacor Pharma
11 May 2017 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.